Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver [Phase 3]
Phase 3 clinical trial update evaluating HX008 in combination with Transcatheter Arterial Chemoembolization (TACE) as first-line treatment f…
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation [Phase 2]
Phase II study investigating the combination of olaparib and pembrolizumab in metastatic melanoma with homologous recombination mutation.
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-11-17Clinical Trial Update: To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma [Phase 2]
Phase 2 clinical trial update evaluating camrelizumab plus SHR1020 for advanced melanoma.
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma. [Phase 2]
Phase 2 trial comparing high-dose interleukin-2 alone versus high-dose interleukin-2 with radiation therapy in metastatic melanoma; results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study [Phase 2]
Phase 2 pilot study evaluating 18F-DOPA-PET imaging in metastatic melanoma patients treated with B-RAF inhibitors.
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis [Phase 2]
Phase 2 trial evaluating cryoablation combined with tislelizumab and lenvatinib in melanoma with liver metastasis is in progress with unknow…
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma [Phase 2]
Phase 2 clinical trial evaluating tumor-infiltrating lymphocytes after combination chemotherapy in metastatic melanoma; results posted but n…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma [Phase 3]
Phase 3 clinical trial evaluating tilosotolimod with ipilimumab versus ipilimumab alone in anti-PD-1 refractory metastatic melanoma was term…
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases [Phase 2]
Phase 2 trial investigating neoadjuvant vemurafenib plus cobimetinib for BRAF-mutant melanoma with palpable lymph node metastases.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial update for AK104, a PD-1/CTLA-4 bispecific antibody, in selected advanced solid tumors and melanoma showing safety and effic…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma [Phase 2]
Phase 2 trial examining avadomide (CC-122) in combination with nivolumab in advanced melanoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating riluzole for unresectable stage III/IV melanoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: A Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab for Subjects With Unresectable or Metastatic Melanoma [Phase 2]
Phase 2 trial of indoximod or placebo plus pembrolizumab or nivolumab in unresectable or metastatic melanoma was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: REduced Frequency ImmuNE Checkpoint Inhibition in Cancers [Phase 2]
Phase 2 clinical trial update on reduced-frequency immune checkpoint inhibition in cancers including renal cell carcinoma and melanoma.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence [Phase 2]
Phase 2 clinical trial comparing matured dendritic cells and Montanide in subjects with high risk of melanoma recurrence has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy [Phase 2]
Phase 2 trial evaluating regorafenib in metastatic solid tumors that progressed after standard therapy has completed, with multiple indicate…
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07). [Phase 2]
Phase 2 trial MASTERKEY-115 evaluated talimogene laherparepvec in combination with pembrolizumab for melanoma after progression on prior ant…
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: PD-1 Inhibitors With or Without Radiation in Advanced Melanoma [Phase 2]
Phase 2 trial evaluating PD-1 inhibitors with or without radiotherapy in patients with advanced melanoma.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: A Phase 2 Study to Assess the Safety and Efficacy of IMO-2125 With 8 mg Ipilimumab in Patients With Metastatic Melanoma [Phase 2]
Phase 2 study evaluating IMO-2125 with 8 mg ipilimumab in metastatic melanoma has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2022-08-01Clinical Trial Update: A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022) [Phase 1, Phase 2]
Phase 1/2 trial evaluating pembrolizumab in combination with trametinib and dabrafenib in advanced melanoma has completed with posted result…
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker [Phase 2]
Phase 2 trial evaluating pembrolizumab in treatment-naïve distant metastatic melanoma with use of C11-AMT PET imaging at baseline as a bioma…
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: Study of PI-88 in Patients With Advanced Melanoma [Phase 1, Phase 2]
Clinical trial update for PI-88 in advanced melanoma spanning Phase 1 and Phase 2, status completed.
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma [Phase 1, Phase 2]
A completed phase 1/2 trial evaluating PI-88 in patients with melanoma and unspecified adult solid tumors.
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716) [Phase 3]
Phase 3 trial assessing pembrolizumab versus placebo in patients with resected high-risk stage II melanoma reports safety and efficacy resul…